Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong Tang

Showing results (1361-1370 of 1,415) with videos related to

Pageof 142
Sort By:
Journal of Clinical and Translational Hepatology|May 23, 2024
Five-year Treatment with Tenofovir Alafenamide Achieves High Rates of Viral Suppression, Alanine Aminotransferase Normalization, and Favorable Bone and Renal Safety in Chinese Chronic Hepatitis B PatientsJinlin Hou, Qin Ning, Zhongping Duan, et al.
Plos Genetics|November 21, 2019
East-Asian Helicobacter pylori strains synthesize heptan-deficient lipopolysaccharideHong Li, Michael Marceau, Tiandi Yang, et al.
Hepatology International|April 12, 2018
Ledipasvir/sofosbuvir for treatment-naive and treatment-experienced Chinese patients with genotype 1 HCV: an open-label, phase 3b studyLai Wei, Qing Xie, Jin Lin Hou, et al.
Alimentary Pharmacology & Therapeutics|June 22, 2021
Association of central obesity with hepatocellular carcinoma in patients with chronic hepatitis B receiving antiviral therapyRong Fan, Junqi Niu, Hong Ma, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|May 12, 2025
[Randomized, double-blind, parallel-controlled, multicenter, equivalence clinical trial of Jiuwei Xifeng Granules(Os Draconis replaced by Ostreae Concha) for treating tic disorder in children]Qiu-Han Cai, Cheng-Liang Zhong, Si-Yuan Hu, et al.
World Journal of Clinical Cases|July 5, 2021
Tenofovir disoproxil fumarate in Chinese chronic hepatitis B patients: Results of a multicenter, double-blind, double-dummy, clinical trial at 96 weeksXiao-Fan Chen, Ya-Nan Fan, Chong-Wen Si, et al.
Journal of Medicinal Chemistry|February 25, 2015
Discovery of imidazo[2,1-b]thiazole HCV NS4B inhibitors exhibiting synergistic effect with other direct-acting antiviral agentsNing-Yu Wang, Ying Xu, Wei-Qiong Zuo, et al.
Bone Marrow Transplantation|January 18, 2022
Clinical outcomes of individualized busulfan-dosing in hematopoietic stem cell transplantation in Chinese children undergoing with therapeutic drug monitoringDuan-Fang Shao, Jun-Hui Li, Tao Hu, et al.
Medicine|August 16, 2019
A randomized, double-blind, double-dummy, controlled, multicenter study of Qingzhong (tenofovir disoproxil fumarate) versus Viread for the treatment of chronic hepatitis B: First-stage results at week 48Rong-Yue Liang, Jing-Hang Xu, Chong-Wen Si, et al.
Hepatology International|April 13, 2019
Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year resultsXieer Liang, Zhiliang Gao, Qing Xie, et al.
Pageof 142

Showing results (1361-1370 of 1,415) with videos related to

Sort By:
Pageof 142
Journal of Clinical and Translational Hepatology|May 23, 2024
Five-year Treatment with Tenofovir Alafenamide Achieves High Rates of Viral Suppression, Alanine Aminotransferase Normalization, and Favorable Bone and Renal Safety in Chinese Chronic Hepatitis B PatientsJinlin Hou, Qin Ning, Zhongping Duan, et al.
Plos Genetics|November 21, 2019
East-Asian Helicobacter pylori strains synthesize heptan-deficient lipopolysaccharideHong Li, Michael Marceau, Tiandi Yang, et al.
Hepatology International|April 12, 2018
Ledipasvir/sofosbuvir for treatment-naive and treatment-experienced Chinese patients with genotype 1 HCV: an open-label, phase 3b studyLai Wei, Qing Xie, Jin Lin Hou, et al.
Alimentary Pharmacology & Therapeutics|June 22, 2021
Association of central obesity with hepatocellular carcinoma in patients with chronic hepatitis B receiving antiviral therapyRong Fan, Junqi Niu, Hong Ma, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|May 12, 2025
[Randomized, double-blind, parallel-controlled, multicenter, equivalence clinical trial of Jiuwei Xifeng Granules(Os Draconis replaced by Ostreae Concha) for treating tic disorder in children]Qiu-Han Cai, Cheng-Liang Zhong, Si-Yuan Hu, et al.
World Journal of Clinical Cases|July 5, 2021
Tenofovir disoproxil fumarate in Chinese chronic hepatitis B patients: Results of a multicenter, double-blind, double-dummy, clinical trial at 96 weeksXiao-Fan Chen, Ya-Nan Fan, Chong-Wen Si, et al.
Journal of Medicinal Chemistry|February 25, 2015
Discovery of imidazo[2,1-b]thiazole HCV NS4B inhibitors exhibiting synergistic effect with other direct-acting antiviral agentsNing-Yu Wang, Ying Xu, Wei-Qiong Zuo, et al.
Bone Marrow Transplantation|January 18, 2022
Clinical outcomes of individualized busulfan-dosing in hematopoietic stem cell transplantation in Chinese children undergoing with therapeutic drug monitoringDuan-Fang Shao, Jun-Hui Li, Tao Hu, et al.
Medicine|August 16, 2019
A randomized, double-blind, double-dummy, controlled, multicenter study of Qingzhong (tenofovir disoproxil fumarate) versus Viread for the treatment of chronic hepatitis B: First-stage results at week 48Rong-Yue Liang, Jing-Hang Xu, Chong-Wen Si, et al.
Hepatology International|April 13, 2019
Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year resultsXieer Liang, Zhiliang Gao, Qing Xie, et al.
Pageof 142